In older patients with AFib who take anticoagulants for stroke prevention, bleeding is increased compared with younger patients, leading physicians to often prescribe lower than recommended doses in older patients. Researchers on the ENGAGE AF-TIMI 48 trial team sought to determine whether patients 80 years and older with AFib benefit from lower-dose anticoagulants, even in the absence of prespecified dose-reduction criteria.

In 2023, there were 81,083 opioid-related overdose deaths in the United States, according to CDC. Many practitioners believe that community-based interventions can aid in reducing the number of deaths, but data related to the effectiveness of such interventions are lacking.

Corey Whetzel, PharmD, JD

Researchers are urgently seeking effective treatments for postacute sequelae of SARS-CoV-2 infection (PASC), commonly known as “Long COVID.” Long COVID affects millions globally, causing a wide range of persistent symptoms such as fatigue, brain fog, shortness of breath, body aches, GI issues, and cardiovascular problems.

Aiya Almogaber, PharmD

Recently, AMA released the results of its 2023 prior authorization physician survey. It showed a continuing and significant concern among physicians regarding the prior authorization process, which they see as a time-consuming barrier to the efficient and effective delivery of care.

Elizabeth Briand

Medication errors are the third leading cause of death in the United States, with an estimated 400,000 hospitalized patients harmed in some way by medication errors every year. Many of these could be avoided through practice changes.

Sonya Collins